Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Expressions of Insulin-Like Growth Factor Receptor-1 and Insulin-Like Growth Factor Binding Protein 3 in Advanced Non-Small-Cell Lung Cancer.
Kim YH, Sumiyoshi S, Hashimoto S, Masago K, Togashi Y, Sakamori Y, Okuda C, Mio T, Mishima M.
Clin Lung Cancer. 2012 Jan 27. [Epub ahead of print]
Related citations
Association of Nuclear YB-1 Localization With Lung Resistance-related Protein and Epidermal Growth Factor Receptor Expression in Lung Cancer.
Hyogotani A, Ito KI, Yoshida K, Izumi H, Kohno K, Amano J.
Clin Lung Cancer. 2012 Jan 25. [Epub ahead of print]
Pemetrexed Therapy in Elderly Patients With Good Performance Status: Analysis of Two Phase III Trials of Patients With Nonsquamous Non-Small-Cell Lung Cancer.
Gridelli C, Brodowicz T, Langer CJ, Peterson P, Islam M, Guba SC, Moore P, Visseren-Grul CM, Scagliotti G.
Clin Lung Cancer. 2012 Jan 20. [Epub ahead of print]
Phase I and II Trials of Vinorelbine With Carboplatin for Patients 75 Years of Age or Older With Previously Untreated Non-Small-Cell Lung Cancer.
Takatani H, Nakamura Y, Nagashima S, Soda H, Kinoshita A, Fukuda M, Fukuda M, Soejima Y, Kasai T, Nakatomi K, Iida T, Oka M, Tsukamoto K, Kohno S.
Clin Lung Cancer. 2012 Jan 18. [Epub ahead of print]
Proton Therapy With Concurrent Chemotherapy for Non-small-cell Lung Cancer: Technique and Early Results.
Hoppe BS, Flampouri S, Henderson RH, Pham D, Bajwa AA, D'Agostino H, Huh SN, Li Z, Mendenhall NP, Nichols RC.
Delay Between the Initial Symptoms, the Diagnosis and the Onset of Specific Treatment in Elderly Patients With Lung Cancer.
Giroux Leprieur E, Labrune S, Giraud V, Gendry T, Cobarzan D, Chinet T.
Comparison of (11)C-Choline PET/CT and Enhanced CT in the Evaluation of Patients With Pulmonary Abnormalities and Locoregional Lymph Node Involvement in Lung Cancer.
Peng Z, Liu Q, Li M, Han M, Yao S, Liu Q.
Clin Lung Cancer. 2011 Dec 17. [Epub ahead of print]
Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non-Small-Cell Lung Cancer After Curative Resection.
Jiang W, Pang XG, Wang Q, Shen YX, Chen XK, Xi JJ.
Clin Lung Cancer. 2011 Dec 15. [Epub ahead of print]
Aberrant Promoter Methylation of CDH13 and MGMT Genes is Associated With Clinicopathologic Characteristics of Primary Non-Small-Cell Lung Carcinoma.
Kontic M, Stojsic J, Jovanovic D, Bunjevacki V, Ognjanovic S, Kuriger J, Puumala S, Nelson HH.
Clin Lung Cancer. 2011 Dec 12. [Epub ahead of print]
Prognostic Significance of Preexisting Interstitial Lung Disease in Japanese Patients with Small-Cell Lung Cancer.
Togashi Y, Masago K, Handa T, Tanizawa K, Okuda C, Sakamori Y, Nagai H, Kim YH, Mishima M.
Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non-Small-Cell Lung Cancer (NSCLC).
Reungwetwattana T, Weroha SJ, Molina JR.
Clin Lung Cancer. 2011 Dec 6. [Epub ahead of print]
Smoking History As a Predictive Factor of Treatment Response in Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
Mitchell P, Mok T, Barraclough H, Strizek A, Lew R, van Kooten M.
Clin Lung Cancer. 2011 Dec 5. [Epub ahead of print]
A randomized phase III trial of combined paclitaxel, carboplatin, and radiation therapy followed by weekly paclitaxel or observation for patients with locally advanced inoperable non-small-cell lung cancer.
Carter DL, Garfield D, Hathorn J, Mundis R, Boehm KA, Ilegbodu D, Asmar L, Reynolds C.
Clin Lung Cancer. 2012 May;13(3):205-13. Epub 2011 Dec 3.
Results of a surgical resection for patients with stage IV non--small-cell lung cancer.
Hanagiri T, Takenaka M, Oka S, Shigematsu Y, Nagata Y, Shimokawa H, Uramoto H, Tanaka F.
Clin Lung Cancer. 2012 May;13(3):220-4. Epub 2011 Dec 3.
Expression and clinical significance of ezrin in non--small-cell lung cancer.
Zhang XQ, Chen GP, Wu T, Yan JP, Zhou JY.
Clin Lung Cancer. 2012 May;13(3):196-204. Epub 2011 Dec 3.
Role of positron emission tomography in the early prediction of response to chemotherapy in patients with non--small-cell lung cancer.
Skoura E, Datseris IE, Platis I, Oikonomopoulos G, Syrigos KN.
Clin Lung Cancer. 2012 May;13(3):181-7. Epub 2011 Dec 1.
Clinical significance of IGF1R expression in non-small-cell lung cancer.
Nakagawa M, Uramoto H, Oka S, Chikaishi Y, Iwanami T, Shimokawa H, So T, Hanagiri T, Tanaka F.
Clin Lung Cancer. 2012 Mar;13(2):136-42. Epub 2011 Dec 1.
The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis.
Zhang LQ, Jiang F, Xu L, Wang J, Bai JL, Yin R, Wu YQ, Meng LJ.
Clin Lung Cancer. 2012 May;13(3):188-95. Epub 2011 Dec 1.
Systematic review of the cost-effectiveness of positron-emission tomography in staging of non--small-cell lung cancer and management of solitary pulmonary nodules.
Cao JQ, Rodrigues GB, Louie AV, Zaric GS.
Clin Lung Cancer. 2012 May;13(3):161-70. Epub 2011 Dec 1.
The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.
Mina N, Soubani AO, Cote ML, Suwan T, Wenzlaff AS, Jhajhria S, Samarah H, Schwartz AG.
Clin Lung Cancer. 2012 Mar;13(2):149-56. Epub 2011 Nov 29.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on